Skip to main content

Table 2 Computation of sample size

From: Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)

Expected prevalence of responders

Number of responders

Number of non responders

Total sample size

50%

82

82

164

33%

63

125

188

28%

59

146

205